PMGC Holdings Inc
ELAB
Detailliertes Diagramm anzeigen
5.606USD
-0.139-2.43%
Handelsschluss 11/04, 16:00（ET）Kurse um 15 Minuten verzögert
8.28MMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
-2.43%
5 Tage
-6.42%
1 Monat
+4.97%
6 Monate
+127.87%
Seit Jahresbeginn
-65.03%
1 Jahr
-80.08%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von PMGC Holdings Inc
Währung: USD Aktualisiert: 2025-11-04Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ sehr gesund. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. Trotz einer schwachen Aktienmarktperformance zeigt das Unternehmen starke Fundamentaldaten. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
PMGC Holdings Inc Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
0
Analysten
--
Aktuelles Rating
--
Kursziel
--
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
PMGC Holdings Inc Highlights
HöhepunkteRisiko
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.
high_profit_growth
high_profit_growth_desc%!(EXTRA string=0.00)
valuation_overestimated
valuation_overestimated_desc%!(EXTRA string=PE, string=0.03)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=11.49K, string=68.59%)
institutional_hold%!(EXTRA string=The Vanguard)
institutional_hold_desc%!(EXTRA string=The Vanguard, string=1.78K)
PMGC Holdings Inc Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
PMGC Holdings Inc Informationen
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.
BörsenkürzelELAB
UnternehmenPMGC Holdings Inc
CEOMr. Graydon Bensler
Websitehttps://pmgcholdings.com/
Verwandte Finanzinstrumente
-0.63%
0.00%
-0.40%
0.00%
-0.11%
0.00%
0.00%
0.00%
+0.15%
-10.53%
0.00%
-0.95%
-0.15%
0.00%
0.00%
-0.18%
+0.00%
0.00%
+0.04%
0.00%Beliebte Symbole
